Market Research Logo

Global Preventable Vaccines Market 2015-2019

Global Preventable Vaccines Market 2015-2019

About Preventable Vaccines

Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from birth to 18 years of age.

TechNavio's analysts forecast the Global Preventable Vaccines market to grow at a CAGR of 10.16 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Preventable Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of preventable vaccines. The report examines the market for vaccines used in humans. It covers only commercialized vaccines for diseases that are vaccine preventable. The report does not cover emerging vaccines for diseases that are not currently vaccine preventable, such as Ebola infection, Epstein-Ban virus infection, Alzheimer's disease, diabetes, Helicobacter pylori infection, multiple sclerosis, Parkinson's disease, or West Nile virus infection.The report has broadly categorized preventable vaccines into two major segments:

  • Adult Preventable Vaccines
  • Pediatric Preventable Vaccines
TechNavio's report, the Global Preventable Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Preventable Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
  • Americas
  • APAC
  • EMEA
Key Vendors
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
Other Prominent Vendors
  • Abbott
  • AstraZeneca
  • Bavarian Nordic
  • Baxter
  • Bharat Biotech
  • Bharat Immunologicals and Biologicals
  • bioCSL
  • Bio Med
  • Crucell
  • Dynavax Technologies
  • Indian Immunologicals
  • Janssen Pharmaceuticals
  • Kaketsuken
  • LG Life Sciences
  • Mitsubishi Tanabe Pharma
  • Lupin
  • Nuron
  • Protein Sciences
  • Panacea Biotec
  • Roche
  • Serum Institute of India
  • Shenzhen Kangtai Biological Products
  • Serum Institute of India
  • Sinovac Biotech
  • S K Chemicals
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals
  • Zydus Cadila
Market Driver
  • Inclusion in NIP
  • For a full, detailed list, view our report
Market Challenge
  • Inadequate Vaccine Coverage
  • For a full, detailed list, view our report
Market Trend
  • Increase in Strategic Alliances
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

TechNavio Announces the Publication of its Research Report – Global Preventable Vaccines Market 2015-2019

TechNavio recognizes the following companies as the key players in the Global Preventable Vaccines Market: GlaxoSmithKline plc, Merck and Co. Inc., Novartis AG, Pfizer Inc. and Sanofi SA

Other Prominent Vendors in the market are: Abbott, AstraZeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bharat Immunologicals and Biologicals, bioCSL, Bio Med, Crucell, Dynavax Technologies, Indian Immunologicals, Janssen Pharmaceuticals, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novartis, Nuron, Panacea Biotec, Protein Sciences, Roche, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, S K Chemicals, Takeda Pharmaceutical, Valeant Pharmaceuticals and Zydus Cadila.

Commenting on the report, an analyst from TechNavio’s team said: “One major trend emerging in the market is the strategic alliances of the vendors in the market, resulting in consolidation. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Large pharmaceutical companies are focused on consolidating their position in the Global Preventable Vaccines market.”

According to the report, the primary driving factor is the inclusion of pediatric vaccines in the national immunization schedule of many countries. This helps increase the consumption of vaccines in the market, thereby boosting growth.

Further, the report states that the inadequate vaccine coverage in the world is a major challenge to the growth of the market. Lack of awareness and negligence among individuals, besides the subsidies offered by governments for a particular age group, are the most prominent factors that decrease these coverage rates.

Companies Mentioned

GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi , Abbott, AstraZeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bharat Immunologicals and Biologicals , bioCSL, Bio Med , Crucell, Dynavax Technologies, Indian Immunologicals, Janssen Pharmaceuticals,Kaketsuken, LG Life Sciences, Mitsubishi Tanabe Pharma, Lupin, Nuron , Protein Sciences, Panacea Biotec, Roche, Serum Institute of India , Shenzhen Kangtai Biological Products , Serum Institute of India, Sinovac Biotech, S K Chemicals,Takeda Pharmaceutical , Valeant Pharmaceuticals, Zydus Cadila

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Vaccine Approval Process
    • Table Vaccine Approval Process
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Global Preventable Vaccines Market 2014-2019 (US$ million)
      • Table Segmentation of Global Preventable Vaccines Market by Category
    • Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019
      • Table Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019 (US$ million)
      • Table Global Preventable Vaccines Market Share by Vaccine Type 2014 and 2019
    • Five Forces Analysis
  • Market Segmentation by Type of Vaccine
    • Table Segmentation of Global Preventable Vaccines Market by Vaccine Type
    • Live Attenuated Vaccine
    • Killed Vaccine
    • Toxoid Vaccine
    • Genetically Modified/Engineered Vaccine
  • Market Segmentation by Product Type
    • Table Segmentation of Global Preventable Vaccines Market by Product Type
    • Polysaccharide Vaccines
    • Conjugate Vaccines
  • Geographical Segmentation
    • Table Segmentation of Global Preventable Vaccines Market by Geography 2014
    • Table Global Preventable Vaccines Market by Region 2014-2019 (US$ million)
  • Global Preventable Vaccines Market by Key Geographies
    • Market Size and Forecast for US
      • Table Preventable Vaccines Market in US 2014-2019 (US$ million)
    • Market Size and Forecast for EU
      • Table Preventable Vaccines Market in EU 2014-2019 (US$ million)
    • Market Size and Forecast for Japan
      • Table Preventable Vaccines Market in Japan 2014-2019 (US$ million)
    • Market Size and Forecast for India
      • Table Preventable Vaccines Market in India 2014-2019 (US$ million)
    • Market Size and Forecast for China
      • Table Preventable Vaccines Market in China 2014-2019 (US$ million)
  • Global Pediatric Preventable Vaccines Market
    • Global Pediatric Preventable Vaccines Market
      • Market Size and Forecast
        • Table Global Pediatric Preventable Vaccines Market 2014-2019 (US$ million)
    • Market Segmentation of Global Pediatric Preventable Vaccines Market
      • Table Segmentation of Global Pediatric Preventable Vaccines Market
    • Global Pediatric Hepatitis Vaccine Market
      • Market Size and Forecast
        • Table Global Pediatric Hepatitis Vaccine Market 2014-2019 (US$ million)
    • Global Pediatric HiB Vaccine Market
      • Market Size and Forecast
        • Table Global Pediatric HiB Vaccine Market 2014-2019 (US$ million)
    • Global Pediatric MMR Vaccine Market
      • Market Size and Forecast
        • Table Global Pediatric MMR Vaccine Market 2014-2019 (US$ million)
    • Global Pediatric Combination Vaccine Market
      • Market Size and Forecast
        • Table Global Pediatric Combination Vaccine Market 2014-2019 (US$ million)
    • Global Pediatric Pneumococcal Vaccine Market
      • Market Size and Forecast
        • Table Global Pediatric Pneumococcal Vaccine Market 2014-2019 (US$ million)
    • Global Pediatric Polio Vaccine Market
      • Market Size and Forecast
        • Table Global Pediatric Polio Vaccine Market 2014-2019 (US$ million)
    • Global Pediatric Varicella Vaccine Market
      • Market Size and Forecast
        • Table Global Pediatric Varicella Vaccine Market 2014-2019 (US$ million)
    • Global Other Pediatric Vaccine Market
      • Market Size and Forecast
        • Table Global Other Pediatric Vaccine Market 2014-2019 (US$ million)
    • Global Pediatric Preventable Vaccines Market 2014 and 2019 (by percentage)
      • Table Segmentation of Global Pediatric Preventable Vaccines Market by Vaccine (2014 and 2019) (US$ million)
      • Table Segmentation of Global Pediatric Preventable Vaccines Market by Vaccine 2014 (in %)
      • Table Segmentation of Global Pediatric Preventable Vaccines Market by Vaccine 2019 (in %)
      • Table Snapshot of Global Pediatric Preventable Vaccines Market by Segments 2014-2019
  • Global Adult Preventable Vaccines Market
    • Market Size and Forecast
      • Table Global Adult Preventable Vaccines Market 2014-2019 (US$ million)
    • Segmentation of Global Adult Preventable Vaccines Market
    • Global Cervical Cancer Vaccine Market
      • Market Size and Forecast
        • Table Global Cervical Cancer Vaccine Market 2014-2019 (US$ million)
    • Global Hepatitis Vaccine Market
      • Market Size and Forecast
        • Table Global Hepatitis Vaccine Market 2014-2019 (US$ million)
    • Global Adult Influenza Vaccine Market
      • Market Size and Forecast
        • Table Global Adult Influenza Vaccine Market 2014-2019 (US$ million)
    • Global Adult Pneumococcal Vaccine Market
      • Market Size and Forecast
        • Table Global Adult Pneumococcal Vaccine Market 2014-2019 (US$ million)
    • Global Adult Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market
      • Market Size and Forecast
        • Table Global Travel, Diphtheria-Tetanus, and Miscellaneous Vaccines Market 2014-2019 (US$ million)
        • Table Segmentation of Global Adult Preventable Vaccines Market by Vaccine (2014 and 2019) (US$ million)
        • Table Segmentation of Global Adult Preventable Vaccines Market by Vaccine 2014 (in %)
        • Table Segmentation of Global Adult Preventable Vaccines Market by Vaccine 2019 (in %)
        • Table Snapshot of Global Adult Preventable Vaccines Market by Segments 2014-2019
  • Key Leading Countries
    • US
    • China
    • Japan
    • India
  • Buying Criteria
    • Table Buying Criteria of Global Preventable Vaccines Market
  • Market Growth Drivers
  • Drivers and their Impact
    • Table Drivers and their Impact on Key Customer Category of Global Preventable Vaccines Market
    • Table Drivers and their Impact on Geographies in Global Preventable Vaccines Market
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • GlaxoSmithKline
        • Table GlaxoSmithKline: Revenue 2013
        • Table GlaxoSmithKline: Vaccine Pipeline
      • Merck
        • Table Merck: Revenue 2013
      • Novartis
        • Table Novartis: Revenue 2013
        • Table Novartis: Vaccine Pipeline
      • Pfizer
        • Table Pfizer: Revenue 2013
      • Sanofi
        • Table Sanofi: Revenue 2013
    • Other Prominent Vendors
  • Key Vendor Analysis
    • GlaxoSmithKline
      • Key Facts
      • Business Overview
      • Business Segmentation
        • Table GlaxoSmithKline: Business Segmentation 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Sales by Geography
        • Table GlaxoSmithKline: Sales by Geography 2013
      • Pipeline Products
        • Table GlaxoSmithKline: Pipeline Products 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Merck
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Merck & Co. Inc.: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Sales by Geography
        • Table Merck & Co. Inc.: Sales by Geography 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Novartis
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table Novartis AG: Business Segmentation
      • Revenue by Business Segmentation
        • Table Novartis AG: Revenue by Business Segmentation 2013
      • Revenue Comparison 2012 and 2013
        • Table Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
      • Sales by Geography
        • Table Novartis AG: Revenue by Geographical Segmentation 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Pfizer
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Pfizer: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Pfizer: Business Segmentation by Revenue 2012 and 2013
      • Geographical Segmentation by Revenue
        • Table Pfizer: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
    • Sanofi
      • Key Facts
      • Business Description
      • Business Segmentation
        • Table Sanofi SA: Business Segmentation
      • Revenue by Business Segmentation
        • Table Sanofi SA: Revenue by Business Segmentation 2013
      • Revenue Comparison 2012 and 2013
        • Table Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
      • Sales by Geography
        • Table Sanofi SA: Sales Revenue by Geographical Segmentation 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report